These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 3136638

  • 1. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
    Anderson JL, Jolivette DM, Fredell PA.
    Am J Cardiol; 1988 Aug 25; 62(6):62D-66D. PubMed ID: 3136638
    [Abstract] [Full Text] [Related]

  • 2. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
    Crozier IG, Ikram H, Kenealy M, Levy L.
    Am J Cardiol; 1987 Mar 01; 59(6):607-9. PubMed ID: 3103410
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 01; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 8. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
    van Wijk LM, Crijns HJ, van Gilst WH, Wesseling H, Lie KI.
    Am Heart J; 1989 Feb 01; 117(2):365-9. PubMed ID: 2492738
    [Abstract] [Full Text] [Related]

  • 9. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF, Neuzner J.
    Z Kardiol; 1996 Feb 01; 85 Suppl 6():45-60. PubMed ID: 9064982
    [Abstract] [Full Text] [Related]

  • 10. Flecainide therapy in patients treated for supraventricular tachycardia with near normal left ventricular function.
    Hughes MM, Trohman RG, Simmons TW, Castle LW, Wilkoff BL, Morant VA, Maloney JD.
    Am Heart J; 1992 Feb 01; 123(2):408-12. PubMed ID: 1736577
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 12. [Flecainide and anti-arrhythmia therapy].
    Croce L, Romano S, Pozzoni L, Lomuscio A.
    Minerva Med; 1988 Mar 25; 79(3):229-34. PubMed ID: 3129677
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
    Furlanello F, Guarnerio M, Inama G, Vergara G, Del Greco M, Bertoldi A, Dallago M.
    Am J Cardiol; 1992 Aug 20; 70(5):19A-25A. PubMed ID: 1509994
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of the anti-arrhythmia effect of intravenous flecainide in supraventricular tachyarrhythmias].
    Garre L, Alvarez A, Cianciulli T, Quiroga J, Califano J, Mautner B.
    Arch Inst Cardiol Mex; 1989 Aug 20; 59(3):241-4. PubMed ID: 2506843
    [Abstract] [Full Text] [Related]

  • 15. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M, Cullen MT, Casadei G.
    Eur Heart J; 1995 Dec 20; 16(12):1943-51. PubMed ID: 8682031
    [Abstract] [Full Text] [Related]

  • 16. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL, DaTorre SD, Platt ML, McCarville SE, Hougham AJ.
    J Am Coll Cardiol; 1991 Feb 20; 17(2):297-303. PubMed ID: 1899432
    [Abstract] [Full Text] [Related]

  • 17. [Rational bases for the therapy of supraventricular tachycardias and their management].
    Rostagno C, Bertini G, Padeletti L, Michelucci A, Del Pace S, Gensini GF.
    Ann Ital Med Int; 1993 Feb 20; 8(4):235-43. PubMed ID: 8161480
    [Abstract] [Full Text] [Related]

  • 18. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
    Nathan AW, Camm AJ, Bexton RS, Hellestrand KJ.
    Clin Cardiol; 1987 May 20; 10(5):317-22. PubMed ID: 3109795
    [Abstract] [Full Text] [Related]

  • 19. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H, Schlepper M.
    Am J Cardiol; 1988 Aug 25; 62(6):56D-61D. PubMed ID: 3136637
    [Abstract] [Full Text] [Related]

  • 20. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 25; 19(6):361-3, 397. PubMed ID: 1821351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.